PHI 40/25 Release of stakeholder submissions - Part B reforms

We would like to advise of the release of individual submissions (responses) to our consultation on PricewaterhouseCoopers’ (PwC) report with recommendations on reforms to Part B of the Prescribed List. 

These submissions complement the high-level summary published in December 2024. This summary should be read in conjunction with the individual submissions. 

For more information visit modernising Part B (human tissue products) of the Prescribed List.